Compass Pathways study shows minimal interaction in psilocybin trials

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Compass Pathways stock hits 52-week high at 14.77 USD Hisse Senetleri 0 11
A Compass Group stock rating reaffirmed by Bernstein on AI growth potential Hisse Senetleri 0 9
A Compass Inc.’s SWOT analysis: stock eyes growth after acquisition Hisse Senetleri 0 28
A Compass Diversified Holdings shareholders elect directors and approve proposals at annual meeting Hisse Senetleri 0 16
A Compass Diversified Holdings exec buys shares worth $258k Hisse Senetleri 0 19
A Compass Diversified stock surges on $292.5M asset sale Hisse Senetleri 0 26
A Earnings call transcript: Compass Q4 2025 sees record revenue, stock up 2.5% Hisse Senetleri 0 19
A Compass to dismiss lawsuit after Zillow ends listing ban Hisse Senetleri 0 26

Benzer konular

Üst